Evidence map›Paper›PMID 39221208›Full record

ArticleMaterials today. Bio2024

Engineered cyanobacteria-Fe

Yize Li, Yali Fan, Jin Gao, Shaohui Zheng, Yujuan Xing, Chunyan He, Shuo Ye, Hongfei Xia, Gezhen Wang, Hui Pan and 7 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Materials today. Bio, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Yize LiSchool of Medical Imaging, Xuzhou Medical University, Xuzhou, 221004, China.
Yali FanSchool of Medical Imaging, Xuzhou Medical University, Xuzhou, 221004, China.
Jin GaoSchool of Medical Imaging, Xuzhou Medical University, Xuzhou, 221004, China.
Shaohui ZhengSchool of Medical Imaging, Xuzhou Medical University, Xuzhou, 221004, China.
Yujuan XingSchool of Medical Imaging, Xuzhou Medical University, Xuzhou, 221004, China.
Chunyan HeSchool of Medical Imaging, Xuzhou Medical University, Xuzhou, 221004, China.
Shuo YeSchool of Medical Imaging, Xuzhou Medical University, Xuzhou, 221004, China.
Hongfei XiaSchool of Medical Imaging, Xuzhou Medical University, Xuzhou, 221004, China.
Gezhen WangSchool of Medical Imaging, Xuzhou Medical University, Xuzhou, 221004, China.
Hui PanSchool of Medical Imaging, Xuzhou Medical University, Xuzhou, 221004, China.
Wei XiaSchool of Medical Imaging, Xuzhou Medical University, Xuzhou, 221004, China.
Meirong SuiSchool of Medical Imaging, Xuzhou Medical University, Xuzhou, 221004, China.
Hanjie WangSchool of Life Sciences, Faculty of Medicine, Tianjin Engineering Center of Micro-Nano Biomaterials and Detection-Treatment Technology, Tianjin Key Laboratory of Function and Application of Biological Macromolecular Structures, Tianjin University, Tianjin, 300072, China.
Jing LiuSchool of Life Sciences, Faculty of Medicine, Tianjin Engineering Center of Micro-Nano Biomaterials and Detection-Treatment Technology, Tianjin Key Laboratory of Function and Application of Biological Macromolecular Structures, Tianjin University, Tianjin, 300072, China.
Manman XieSchool of Medical Imaging, Xuzhou Medical University, Xuzhou, 221004, China.
Kai XuSchool of Medical Imaging, Xuzhou Medical University, Xuzhou, 221004, China.
Yingying ZhangSchool of Medical Imaging, Xuzhou Medical University, Xuzhou, 221004, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The combination of photodynamic therapy (PDT)-immunotherapy has brought much hope for cancer patients. However, the hypoxia tumor microenvironment (TME) can regulate tumor angiogenesis and inhibit immune response, thus limiting the therapeutic effects. In this paper, engineered cyanobacteria-M2-like tumor-associated macrophages (TAMs) targeting peptide modified Fe

Indexed as

Engineered cyanobacteriaImmunotherapyPhotodynamic therapyReprogramming and repolarization of M2-like TAMs

Identifiers

PMID39221208
PMCPMC11364136

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.